首页> 外文期刊>Poultry Science >Immune response in domestic ducks following intradermal delivery of inactivated vaccine against H5N1 highly pathogenic avian influenza virus adjuvanted with oligodeoxynucleotides containing CpG motifs
【24h】

Immune response in domestic ducks following intradermal delivery of inactivated vaccine against H5N1 highly pathogenic avian influenza virus adjuvanted with oligodeoxynucleotides containing CpG motifs

机译:皮内注射灭活的H5N1高致病性禽流感病毒灭活疫苗后,家鸭的免疫应答与含有CpG基序的寡脱氧核苷酸佐剂

获取原文
获取原文并翻译 | 示例
           

摘要

Ducks are a natural reservoir for H5N1 highly pathogenic avian influenza (HPAI) viruses, which produces a range of clinical outcomes from asymptomatic infections to severe disease with mortality. Vaccination against HPAI is one of the few methods available for controlling avian influenza virus (AIV) infection in domestic ducks; therefore, it is necessary to improve vaccine efficacy against HPAI in domestic ducks. However, few studies have focused on enhancing the immune response by testing alternative administration routes and adjuvants. While attempting to maximize the efficacy of a vaccine, it is important to select an appropriate vaccine delivery route and adjuvant to elicit an enhanced immune response. Although several studies have indicated that the vaccination of ducks against HPAI viruses has offered protection against lethal virus challenge, the immunogenicity of the vaccine still requires improvement. In this study, we characterized the immune response following a novel vaccination strategy against H5N1 HPAI virus in domestic ducks. Our novel intradermal delivery system and the application of the cytosine-phosphodiesterguanine (CpG) oligodeoxynucleotide (ODN) adjuvant allowed us to obtain information regarding the sustained vaccine immunity. Compared with the intramuscular route of vaccination, the intradermal route resulted in higher antibody titer as well as lower antibody deviation following secondary vaccination. In addition, the use of a CpG-ODN adjuvant had a dose-sparing effect on antibody titer. Furthermore, when a high dose of antigen was used, the CpG-ODN-adjuvanted vaccine maintained a high mean antibody titer. This data demonstrates that intradermal immunization combined with administration of CpG-ODN as an adjuvant may be a promising strategy for improving vaccine efficacy in domestic ducks.
机译:鸭子是H5N1高致病性禽流感(HPAI)病毒的天然库,从无症状感染到严重的致死性疾病,其产生一系列的临床结果。针对高致病性禽流感的疫苗接种是控制家禽中禽流感病毒(AIV)感染的几种可用方法之一。因此,有必要提高家鸭对HPAI的疫苗效力。然而,很少有研究致力于通过测试替代的给药途径和佐剂来增强免疫应答。在试图使疫苗的效力最大化的同时,重要的是选择适当的疫苗递送途径和佐剂以引发增强的免疫应答。尽管一些研究表明,针对HPAI病毒的鸭疫苗已经提供了针对致命病毒攻击的保护,但疫苗的免疫原性仍需要改进。在这项研究中,我们表征了针对家鸭的H5N1 HPAI病毒的新型疫苗接种策略后的免疫应答。我们新颖的皮内递送系统和胞嘧啶-磷酸二酯鸟嘌呤(CpG)寡脱氧核苷酸(ODN)佐剂的应用使我们可以获得有关持续疫苗免疫的信息。与肌内接种途径相比,皮内途径在二次接种后导致更高的抗体滴度和更低的抗体偏差。另外,使用CpG-ODN佐剂对抗体效价具有剂量节省作用。此外,当使用高剂量的抗原时,CpG-ODN佐剂疫苗保持了较高的平均抗体滴度。该数据表明皮内免疫与CpG-ODN佐剂联合给药可能是提高家禽疫苗效力的有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号